(Q42740297)

6 November 2017

Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy (English)

1 reference

6 November 2017

1 reference

1 reference

1 reference

Yoo-Young Lee

1

1 reference

6 November 2017

Chel Hun Choi

2

1 reference

6 November 2017

In-Gu Do

3

1 reference

6 November 2017

Sang Yong Song

4

1 reference

6 November 2017

Wooseok Lee

5

1 reference

6 November 2017

Hwang Shin Park

6

1 reference

6 November 2017

Tae Jong Song

7

1 reference

6 November 2017

Min Kyu Kim

8

1 reference

6 November 2017

Tae-Joong Kim

9

1 reference

6 November 2017

Jeong-Won Lee

10

1 reference

6 November 2017

Duk-Soo Bae

11

1 reference

6 November 2017

Byoung-Gie Kim

12

1 reference

6 November 2017

language of work or name

English

0 references

publication date

13 May 2011

1 reference

6 November 2017

1 reference

6 November 2017

122

1 reference

6 November 2017

2

1 reference

6 November 2017

361-365

1 reference

6 November 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Role of copper transporters in the uptake and efflux of platinum containing drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Regulation of copper transporter 2 expression by copper and cisplatin in human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Copper transporter 2 regulates the cellular accumulation and cytotoxicity of Cisplatin and Carboplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Altered MicroRNA expression in cervical carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

The role of copper transporters in the development of resistance to Pt drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Characterization of the hCTR1 gene: genomic organization, functional expression, and identification of a highly homologous processed gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Contribution of the major copper influx transporter CTR1 to the cellular accumulation of cisplatin, carboplatin, and oxaliplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

The internalization and degradation of human copper transporter 1 following cisplatin exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Modulation ofcis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Effects of the loss of Atox1 on the cellular pharmacology of cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Prognostic value of the Cu-transporting ATPase in ovarian carcinoma patients receiving cisplatin-based chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

Chemosensitivity and chemoresistance testing in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2011.04.025

10.1016/J.YGYNO.2011.04.025

7 January 2021

Identifiers

DOI

1 reference

6 November 2017

1 reference